Around the Practice: Optimizing First-Line Therapy in Transplant-Ineligible Multiple Myeloma

home / around-the-practice / around-the-practice-optimizing-first-line-therapy-in-transplant-ineligible-multiple-myeloma

A panel of experts discuss strategies for optimizing first-line therapy for transplant-ineligible patients with newly diagnosed multiple myeloma.

EP. 1: Challenges in Treating Transplant-Ineligible Multiple Myeloma

C. Ola Landgren, MD, PhD;Cristina Gasparetto, MD;Craig Hofmeister, MD, MPH;Peter Voorhees, MD

September 30th 2021

Shared insight on the difficulties of transplant-ineligible newly diagnosed multiple myeloma and how to optimally approach treatment.

EP. 2: Multiple Myeloma: Transplant Ineligibility and Goals of Therapy

C. Ola Landgren, MD, PhD;Cristina Gasparetto, MD;Craig Hofmeister, MD, MPH;Peter Voorhees, MD

September 30th 2021

Panelists elucidate how to determine transplant ineligibility and the goals of therapy while managing a patient with multiple myeloma.

EP. 3: Transplant-Ineligible Multiple Myeloma: Assessing Response to Therapy

C. Ola Landgren, MD, PhD;Craig Hofmeister, MD, MPH;Cristina Gasparetto, MD;Peter Voorhees, MD

October 7th 2021

Shared insight on how best to assess a patient’s response to therapy for transplant-ineligible multiple myeloma.

EP. 4: Transplant-Ineligible MM: Treatment After Adequate Response to Therapy

C. Ola Landgren, MD, PhD;Cristina Gasparetto, MD;Craig Hofmeister, MD, MPH;Peter Voorhees, MD

October 7th 2021

A panel of experts reflects on appropriate actions to take after a patient achieves adequate response to therapy for transplant-ineligible multiple myeloma.

EP. 5: Treatment Options for First-Line Therapy in Transplant-Ineligible MM

C. Ola Landgren, MD, PhD;Cristina Gasparetto, MD;Craig Hofmeister, MD, MPH;Peter Voorhees, MD

October 14th 2021

In-depth considerations for available frontline therapy regimens for patients with transplant-ineligible multiple myeloma.

EP. 6: Patient Case #1: A 75-Year-Old Woman With Newly Diagnosed MM

C. Ola Landgren, MD, PhD;Cristina Gasparetto, MD;Craig Hofmeister, MD, MPH;Peter Voorhees, MD

October 14th 2021

Experts review the case of a 75-year-old woman with newly diagnosed multiple myeloma and discuss treatment selection, continuation, reduction, and duration.

EP. 7: Patient Case #2: A 77-Year-Old Man With Newly Diagnosed MM

C. Ola Landgren, MD, PhD;Cristina Gasparetto, MD;Craig Hofmeister, MD, MPH;Peter Voorhees, MD

October 21st 2021

Panelists discuss the case of a 77-year-old man with newly diagnosed multiple myeloma who wishes to discontinue therapy after achieving a very good partial response.

EP. 8: Future Directions in Multiple Myeloma Care: Improvements and Unmet Needs

C. Ola Landgren, MD, PhD;Cristina Gasparetto, MD;Craig Hofmeister, MD, MPH;Peter Voorhees, MD

October 21st 2021

After reviewing implications of the MAIA study in multiple myeloma, experts consider unmet needs and future directions in care.